Shenzhen People's Hospital
OrganisationROR
Trials
Status unknown, 1 person, 17 Aug 2026
Early phase 1, Status unknown, 143 people, 31 Jul 2026
Status unknown, 600 people, 24 Jul 2026
REmifentanil And Dexmedetomidine for EarlY Intensive Blood Pressure Lowering in ICH.
Collaborator, Not yet recruiting, 1,116 people, 10 Jul 2026
Phase 2, Recruiting, 196 people, 26 Jan 2026
Phase 3, Status unknown, 100 people, 6 Dec 2022
Phase 4, Completed, 75 people, 28 Oct 2022
Collaborator, Phase 2, Active, not recruiting, 41 people, 1 Sept 2022
Collaborator, Phase 3, Status unknown, 300 people, 21 Jul 2022
Collaborator, Phase 3, Completed, 190 people, 8 Dec 2021
Phase 2/3, Status unknown, 122 people, 3 Nov 2021
Phase 2/3, Withdrawn, 0 people, 1 Oct 2021
Phase 2/3, Completed, 90 people, 27 Sept 2021
Phase 4, Completed, 52 people, 11 Jun 2020
Phase 3, Status unknown, 48 people, 4 Sept 2018
Phase 4, Status unknown, 20 people, 18 Jul 2018
Collaborator, Phase 3, Status unknown, 590 people, 29 Jun 2017
Sources: trialsearch.who.int, clinicaltrials.gov